Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Medizintechnik / Medizinprodukte
  • weitere Studien Medizintechnik / Medizinprodukte
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Island
  • Italien
  • Kroatien
  • Lettland
  • Litauen
  • Luxemburg
  • Malta
  • Mazedonien
  • Moldawien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Zypern
  • Asien / Pazifik
  • Bangladesch
  • China
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Ghana
  • Iran
  • Israel
  • Marokko
  • Nigeria
  • Oman
  • Saudi Arabien
  • South Africa
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Kolumbien
  • Mexiko
  • Peru
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • AIK - Kohlhaas & Partner
  • Biopharm Reports
  • Business Insights
  • cbc market intelligence
  • data information intelligence
  • Datamonitor
  • Euromonitor
  • GBI Research
  • GfK Living
  • Global Markets Direct
  • Global Research & Data Services
  • GlobalData
  • IC CONSULTING GMBH
  • ICD Research
  • IFH RETAIL CONSULTANTS GmbH
  • Kable
  • Koncept Analytics
  • MarketLine
  • MarketsandMarkets
  • Technavio
  • Zukunftsinstitut
  • Filter zurücksetzen
Sprache
  • Deutsch
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • Filter zurücksetzen
laedt

Marktanalyse - Global Life Sciences Tools & Services

MarketLine

MarketLine

5 / 2012
29 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

228,15 €*
( 295,00 $)
PDF-Datei per E-Mail, Single User License , versandkostenfrei
570,77 €*
( 738,00 $)
PDF-Datei per E-Mail, Enterprise License , versandkostenfrei


Introduction

Global Life Sciences Tools & Services industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global life sciences tools & services market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The life sciences tools & services market is comprised of companies enabling the drug discovery, development and production continuum by providing analytical tools, instruments, consumables & supplies, clinical trial services and contract research services. However, the market value in this profile only includes revenues from clinical trial services and other contract research services from firms primarily servicing the pharmaceutical and biotechnology industries. All currency conversions used in the report are calculated at constant annual average 2011 exchange rates.

*The global life sciences tools & services market had total revenue of $20.3 billion in 2011, representing a compound annual growth rate (CAGR) of 7.6% between 2007 and 2011.

*The clinical (Phase I-IV) segment was the market's most lucrative in 2011, with total revenue of $8.5 million, equivalent to 41.7% of the market's overall value.

*The performance of the market is forecast to decelerate, with an anticipated CAGR of 6.7% for the five-year period 2011 - 2016, which is expected to drive the market to a value of $28 billion by the end of 2016

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the life sciences tools & services market in the global

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globallife sciences tools & services market

Leading company profiles reveal details of key life sciences tools & services market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Global life sciences tools & services market with five year forecasts



Key Questions Answered

What was the size of the Global life sciences tools & services market by value in 2011?

What will be the size of the Global life sciences tools & services market in 2016?

What factors are affecting the strength of competition in the Global life sciences tools & services market?

How has the market performed over the last five years?

Who are the top competitiors in the global's life sciences tools & services market?
TABLE OF CONTENTS

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market Segmentation 9

Category segmentation 9

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 17

Degree of rivalry 18

Leading Companies 19

Covance Inc. 19

ICON plc 22

Pharmaceutical Product Development, Inc. 25

Quintiles Transnational Corp. 26

Appendix 27

Methodology 27

Industry associations 28

Related MarketLine research 28



LIST OF TABLES

Table 1: Global life sciences tools & services market value: $ billion, 2007—11 8

Table 2: Global life sciences tools & services market category segmentation: $ billion, 2011 9

Table 3: Global life sciences tools & services market geography segmentation: $ billion, 2011 10

Table 4: Global life sciences tools & services market share: % share, by value, 2011 11

Table 5: Global life sciences tools & services market value forecast: $ billion, 2011—16 12

Table 6: Covance Inc.: key facts 19

Table 7: Covance Inc.: key financials ($) 20

Table 8: Covance Inc.: key financial ratios 20

Table 9: ICON plc: key facts 22

Table 10: ICON plc: key financials ($) 23

Table 11: ICON plc: key financial ratios 23

Table 12: Pharmaceutical Product Development, Inc.: key facts 25

Table 13: Quintiles Transnational Corp.: key facts 26



LIST OF FIGURES

Figure 1: Global life sciences tools & services market value: $ billion, 2007—11 8

Figure 2: Global life sciences tools & services market category segmentation: % share, by value, 2011 9

Figure 3: Global life sciences tools & services market geography segmentation: % share, by value, 2011 10

Figure 4: Global life sciences tools & services market share: % share, by value, 2011 11

Figure 5: Global life sciences tools & services market value forecast: $ billion, 2011—16 12

Figure 6: Forces driving competition in the global life sciences tools & services market, 2011 13

Figure 7: Drivers of buyer power in the global life sciences tools & services market, 2011 14

Figure 8: Drivers of supplier power in the global life sciences tools & services market, 2011 15

Figure 9: Factors influencing the likelihood of new entrants in the global life sciences tools & services market, 2011 16

Figure 10: Factors influencing the threat of substitutes in the global life sciences tools & services market, 2011 17

Figure 11: Drivers of degree of rivalry in the global life sciences tools & services market, 2011 18

Figure 12: Covance Inc.: revenues & profitability 21

Figure 13: Covance Inc.: assets & liabilities 21

Figure 14: ICON plc: revenues & profitability 24

Figure 15: ICON plc: assets & liabilities 24

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: